You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博騰股份(300363.SZ)擬向海步醫藥增資5000萬元
格隆匯 10-26 17:58

格隆匯 10 月 26日丨博騰股份(300363.SZ)公佈,為促進公司一體化CDMO製藥服務平台的戰略佈局,提升公司多客户產品業務API產品的國內註冊能力,補足多客户產品業務及製劑CDMO業務的研發團隊能力和產品管線,為製劑CDMO業務快速進入仿製藥業務奠定業務和客户羣基礎,公司擬以自有資金人民幣5000萬元向北京海步醫藥科技股份有限公司(“海步醫藥”)增資。

海步醫藥具備較好的研發和技術能力,同時其內部的管理規範有序,通過此次投資,公司可藉助其較為出色的研發及註冊能力,提升公司多客户產品業務的國內註冊能力,補足研發團隊能力和產品管線,與公司現有多客户產品業務形成良好的互補和協同。同時,此次與海步醫藥的戰略合作與公司製劑CDMO業務的戰略定位中仿製藥策略相匹配,有助於公司製劑CDMO業務更快進入仿製藥市場,有利於增加製劑CRO業務的業務和客户羣基礎,為公司製劑CDMO業務的戰略佈局添磚加瓦。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account